ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 41 filers reported holding ANNOVIS BIO INC in Q4 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $39,502 | -30.8% | 6,858 | +42.9% | 0.00% | 0.0% |
| Q1 2024 | $57,096 | +623.6% | 4,798 | +1037.0% | 0.00% | – |
| Q4 2023 | $7,891 | +29.5% | 422 | -34.3% | 0.00% | – |
| Q3 2023 | $6,093 | -17.9% | 642 | +23.7% | 0.00% | – |
| Q2 2023 | $7,417 | +18917.9% | 519 | -79.7% | 0.00% | -100.0% |
| Q1 2023 | $39 | +85.7% | 2,561 | +67.9% | 0.00% | 0.0% |
| Q4 2022 | $21 | -99.9% | 1,525 | -9.8% | 0.00% | – |
| Q3 2022 | $23,000 | +91.7% | 1,690 | +152.6% | 0.00% | – |
| Q4 2021 | $12,000 | +71.4% | 669 | +194.7% | 0.00% | – |
| Q3 2021 | $7,000 | -88.9% | 227 | -90.0% | 0.00% | -100.0% |
| Q1 2021 | $63,000 | +950.0% | 2,259 | +190.4% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 778 | -37.1% | 0.00% | – |
| Q3 2020 | $6,000 | +50.0% | 1,236 | +20.2% | 0.00% | – |
| Q2 2020 | $4,000 | – | 1,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmond Asset Management, LLC | 34,010 | $456,754 | 0.16% |
| Sterling Investment Advisors, Ltd. | 32,474 | $436,126 | 0.16% |
| Wescott Financial Advisory Group, LLC | 41,607 | $558,782 | 0.12% |
| Merit Financial Group, LLC | 43,150 | $579,505 | 0.02% |
| Modera Wealth Management, LLC | 30,513 | $409,790 | 0.02% |
| Koshinski Asset Management, Inc. | 10,000 | $134,300 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,600 | $316,948 | 0.01% |
| Cannell & Co. | 10,000 | $134,300 | 0.01% |
| IFP Advisors, Inc | 4,600 | $44 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,525 | $21 | 0.00% |